ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,666 | -8.6% | 135,079 | +3.5% | 3.39% | +9.2% |
| Q2 2023 | $4,011 | -22.0% | 130,487 | -8.6% | 3.11% | -18.5% |
| Q1 2023 | $5,143 | +4.9% | 142,748 | +15.0% | 3.81% | -2.8% |
| Q4 2022 | $4,904 | -99.9% | 124,090 | -9.6% | 3.92% | -10.0% |
| Q3 2022 | $5,513,000 | -12.2% | 137,206 | -8.2% | 4.35% | +2.8% |
| Q2 2022 | $6,280,000 | -26.4% | 149,389 | -25.6% | 4.24% | +10.9% |
| Q1 2022 | $8,527,000 | +6.6% | 200,692 | 0.0% | 3.82% | +0.4% |
| Q4 2021 | $7,998,000 | +13.9% | 200,692 | +3.3% | 3.81% | +18.5% |
| Q3 2021 | $7,022,000 | +75.4% | 194,305 | +99.0% | 3.21% | +69.7% |
| Q2 2021 | $4,003,000 | – | 97,656 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |